1. Karyopharm Appoints J. Scott Garland to Its Board of Directors

    Karyopharm Appoints J. Scott Garland to Its Board of Directors

    NEWTON, Mass. -- Karyopharm Therapeutics Inc. , a clinical-stage pharmaceutical company, today announced the appointment of J. Scott Garland, Senior Vice President and Chief Commercial Officer of Relypsa ...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Quotes

    1. Scott brings nearly 25 years of commercial leadership to Karyopharm from his experience at Genentech, Amgen, Merck, Exelixis and now at Relypsa.
    2. I see significant opportunity in Karyopharm's approach to developing first-in-class cancer treatments through nuclear transport targets.
  3. Topics Mentioned